The prevailing mood among immunologists and oncologists concerning immunotherapy of
cancer is still one of gloom. Indeed, as of this writing, the impact of immunotherapy on …

Viral diseases are a major cause of morbidity and mortality after hemopoietic stem cell
transplantation. Because viral complications in these patients are clearly associated with the …

Epstein Barr virus (EBV)+ Hodgkin's disease (HD) expresses clearly identified tumor
antigens derived from the virus and could, in principle, be a target for adoptive …

Summary Background Epstein-Barr virus (EBV)-associated posttransplantation
lymphoproliferative disease (PTLD) is a common, often fatal, complication of bone-marrow …

Epstein-Barr virus (EBV)–associated posttransplantation lymphoproliferative disorders
(PTLDs) are a well-recognized complication of immunosuppression in solid organ transplant …

The adoptive transfer of antigen-specific cytotoxic T lymphocytes (CTLs) is a promising
therapeutic approach for a number of diseases. To overcome the difficulty in generating …

In the absence of immune surveillance, Epstein-Barr virus (EBV)-infected B cells generate
neoplasms in vivo and transformed cell lines in vitro. In an in vitro system which modeled the …

Cord blood transplantation, which has lower risk of graft-versus-host disease than bone
marrow transplantation, might have higher risk of infections. A system to quantify four …

Techniques for the quantitation of virus-specific and alloantigen-reactive T cells vary in their
measurement of clinically relevant T-cell effector populations, their sensitivity and …

Abstract Latent Epstein-Barr virus (EBV) infection is associated with a heterogeneous group
of malignancies, including Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal …